The study, which involved a sleeping aid known as suvorexant that...
Category:
Health
Latest
Too much insulin can be as dangerous as too little: Research
While our body finely tunes insulin production, patients who are...
CBI asks ex-J&K governor Satya Pal Malik to answer queries related to insurance ‘scam’
Satya Pal Malik,former Governor, Jammu and Kashmir Unknown...
Phase-3 trial of Bharat Biotech’s Covaxin commences in AIIMS
Besides, Covaxin, four other vaccines are under different phases of clinical trial in India with the Serum Institute of India conducting phase-three trial of the Oxford-Astrazeneca Covid-19 vaccine while the indigenously developed vaccine by Zydus Cadila has completed phase-two clinical trial in the country.
Over 50,000 Ayushman Bharat Health and Wellness Centres operational across country
AstraZeneca faces more Covid-19 vaccine questions after manufacturing error
In a statement, Oxford said a difference in manufacturing processes led to later phases of the trials having a half-dose given instead of a full one. When it was apparent that a lower dose was used, it was discussed with regulators, and an agreement was reached to push ahead with the two regimens, the statement said.
The biggest threat to Covid-19 vaccination could be fake news and misinformation
“The coronavirus disease is the first pandemic in history in which technology and social media are being used on a massive scale to keep people safe, informed, productive and connected,” the WHO said.
“At the same time, the technology we rely on to keep connected and informed is enabling and amplifying an infodemic that continues to undermine the global response and jeopardises measures to control the pandemic.”
Covid vaccine rush in China raises fears of booming black market
As developers from AstraZeneca Plc to Pfizer Inc. near the finish line for their coronavirus vaccines, nations are preparing for the challenge of rolling them out, with inevitable supply shortages fueling concerns about inequitable distribution and even the emergence of illegal markets. One place where vaccine delivery is already being road-tested is China, which has allowed local developers’ shots for emergency use since mid-year.
Europe’s drugs watchdog expects first marketing application for coronavirus vaccine in days
The European Medicines Agency (EMA) did not name the company it expects to file the application, but Pfizer Inc and BioNTEch are the most advanced in the regulatory process among the three companies that have published late-stage trial data for their vaccines.
COVID-19 pandemic could be stopped if at least 70% public wore face masks consistently: Study
“The highly efficacious facemask, such as surgical masks with an estimated efficacy of around 70 per cent, could lead to the eradication of the pandemic if at least 70 per cent of the residents use such masks in public consistently,” the scientists, including Sanjay Kumar from the National University of Singapore, wrote in the study
Adults, children must move more to stay fit in pandemic era – WHO
And people of all ages must compensate for growing sedentary behaviour with physical activity to ward off disease and add years to their lives, the WHO said, launching its “Every Move Counts” campaign.
“Increasing physical activity not only helps prevent and manage heart disease, type-2 diabetes and cancer, it also reduces symptoms of depression and anxiety, reduces cognitive decline including Alzheimer’s and improves memory,” Ruediger Krech, WHO director for health promotion, told a news briefing.
No benefit seen from plasma treatment in severe COVID-19; virus may hurt male fertility
“The possibility that COVID-19 damages the testes and impacts fertility … warrants gonadal function evaluation in men infected with COVID-19, or who have recovered from COVID-19, and desire fertility,” the Miami team concluded in a report published in the World Journal of Men’s Health.
Global coronavirus cases surpass 60 million infections
An analysis of the Reuters data showed the rate of new infections picking up globally. It took just 17 days to go from 50 million cases to 60 million, compared with the 21 days it took to go from 40 million to 50 million. Around 580,000 cases have been reported each day over the past week and around half of all cases since the start of the pandemic were reported over the past 70 days.
In Europe, 1 million new cases were recorded over just five days, for a total of more than 16 million cases, including 365,000 deaths.